Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-22-026087
Date:2022-04-26
Issuer: ATYR PHARMA INC (LIFE)
Original Submission Date:

Reporting Person:

COUGHLIN TIMOTHY
C/O ATYR PHARMA, INC.
3545 JOHN HOPKINS COURT SUITE 250 SAN DIEGO, CA 92121

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2022-04-26 deemed execution date A 6,000 (a) common stock 6,000 $0.00 6,000 direct
Footnotes
IDfootnote
f1 each restricted stock unit (rsu) represents a contingent right to receive one share of the issuer's common stock.
f2 the rsus, granted pursuant to the issuer's non-employee director compensation policy, vest in full on the earlier of (i) april 26, 2023 or (ii) the issuer's 2023 annual meeting of stockholders, subject to the reporting person's continued service on the board of directors.
WhaleWisdom Logo

Elevate your investments